NSE filing, NSE: ETERNAL. Summary written from the filing by ALFA Finder's alert engine.
Eternal Ltd: key numbers
- Share price
- ₹326.00
- Market cap
- ₹3,14,601 Cr
- Revenue (annual)
- ₹54,364 Cr
- Net profit (annual)
- ₹366.0 Cr
- P/E (TTM)
- 638.1×Sector 61.5×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 33.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Eternal Ltd
All →Eternal Earnings Call Transcript: Key Takeaways
Q2FY27 call disclosed no financial figures. Management held food margins flattish for 1–2 years, reinvested in quick commerce expansion, maintained the $1B FY29 Adjusted EBITDA guide, and declined to quantify key metrics.
Eternal Acquisition Worth ₹156 Cr
Eternal Ltd agreed to acquire Mygate (Vivish Technologies) for ₹156 Crore via a 16:1 Adonmo share swap. Board-approved deal is set to close by December 5, 2026.
- Value
- ₹156.0 Cr
- Execution
- On or before December 5, 2026
Eternal Merger & Restructuring Worth ₹130.8 Cr
Eternal Limited sold its India going-out business to subsidiary ZEPL for ₹130.76 Crore. The board-approved slump sale is a related-party transaction at arm's length.
- Value
- ₹130.8 Cr
- Execution
- Expected completion by 20-Nov-2026
Eternal Other Announcement
Eternal Limited submitted its Monitoring Agency Report for the quarter ended September 30, 2026, confirming that the QIP proceeds utilization aligns with the original objects.
Eternal Business Update
Eternal Ltd filed a Q2FY27 shareholders' letter under Reg 30, containing the CEO's strategy Q&A on a new AI product (dark.ai) and non-GAAP headline metrics.
Eternal Q2 FY27 Results: Net Profit ₹125 Cr, Up 92.3% YoY
Eternal Ltd reported revenue from operations of ₹24,138 Cr (+77.6% YoY) and net profit of ₹125 Cr (+92.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹125 Cr · +92.3% YoY
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.